• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Ira Klein, MD, Discusses Quality Measures in Oncology

Article

Ira Klein, MD, MBA, FACP, chief medical officer, National Accounts Clinical Sales & Strategy, Aetna, addresses measurement programs used in oncology.

Ira Klein, MD, MBA, FACP, chief medical officer, National Accounts Clinical Sales & Strategy, Aetna, addresses measurement programs used in oncology. Dr Klein says that measurement is a driver for value and healthcare in the future. Quality measures, such as QOPI and HEDIS, allow oncologists to measure how they should be rewarded and recognized for making improvement.

Related Videos
Dr Susan Vadaparampil
Luke Messac at ISC 2026
Ava Liberman at ISC 2026
Alison Holman at ISC 2026
Dr Ameet Patel
Linda Stein Gold, MD
Dr. Emily Fisher at ISC 2026
Angelina Rose Wronski, RN, BS at ISC 2026
Margaret Krackeler, MD
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.